- Home
- Publications
- Publication Search
- Publication Details
Title
Science gone translational: the OX40 agonist story
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 244, Issue 1, Pages 218-231
Publisher
Wiley
Online
2011-10-21
DOI
10.1111/j.1600-065x.2011.01069.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Self-Antigen Prevents CD8 T Cell Effector Differentiation by CD134 and CD137 Dual Costimulation
- (2014) S. Bandyopadhyay et al. JOURNAL OF IMMUNOLOGY
- IL-12 Is Required for Anti-OX40-Mediated CD4 T Cell Survival
- (2014) C. E. Ruby et al. JOURNAL OF IMMUNOLOGY
- OX40 Costimulatory Signals Potentiate the Memory Commitment of Effector CD8+ T Cells
- (2014) S. F. Mousavi et al. JOURNAL OF IMMUNOLOGY
- OX40 Drives Protective Vaccinia Virus-Specific CD8 T Cells
- (2014) S. Salek-Ardakani et al. JOURNAL OF IMMUNOLOGY
- Immune Effects of Trastuzumab
- (2012) Marianna Nuti et al. Journal of Cancer
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- Impact of tumour volume on the potential efficacy of therapeutic vaccines
- (2011) J. L. Gulley et al. Current Oncology
- 4-1BB Signaling Synergizes with Programmed Death Ligand 1 Blockade To Augment CD8 T Cell Responses during Chronic Viral Infection
- (2011) V. Vezys et al. JOURNAL OF IMMUNOLOGY
- Targeting OX40 Promotes Lung-Resident Memory CD8 T Cell Populations That Protect against Respiratory Poxvirus Infection
- (2011) S. Salek-Ardakani et al. JOURNAL OF VIROLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
- (2011) Antonella Sistigu et al. Seminars in Immunopathology
- Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
- (2010) Michael Croft Annual Review of Immunology
- Adoptive T cell therapy of cancer
- (2010) Malcolm K Brenner et al. CURRENT OPINION IN IMMUNOLOGY
- The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice
- (2010) Shahram Salek-Ardakani et al. JOURNAL OF CLINICAL INVESTIGATION
- OX40 is required for regulatory T cell–mediated control of colitis
- (2010) Thibault Griseri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- OX40 Ligand Regulates Inflammation and Mortality in the Innate Immune Response to Sepsis
- (2010) M. Karulf et al. JOURNAL OF IMMUNOLOGY
- Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice
- (2010) Michael J. Gough et al. JOURNAL OF IMMUNOTHERAPY
- Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
- (2010) Sara M. Mangsbo et al. JOURNAL OF IMMUNOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade
- (2010) Jeffrey Weber SEMINARS IN ONCOLOGY
- Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge
- (2009) Vasileios Bekiaris et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo
- (2009) William L. Redmond et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Toll-like receptor agonists in cancer therapy
- (2009) Sylvia Adams Immunotherapy
- OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
- (2009) Daniel Hirschhorn-Cymerman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right
- (2009) C. E. Ruby et al. JOURNAL OF IMMUNOLOGY
- Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
- (2009) Nicola Normanno et al. Nature Reviews Clinical Oncology
- T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
- (2008) R. Houot et al. BLOOD
- OX40 Agonist Therapy Enhances CD8 Infiltration and Decreases Immune Suppression in the Tumor
- (2008) M. J. Gough et al. CANCER RESEARCH
- Multiple roles for CD4+T cells in anti-tumor immune responses
- (2008) Richard Kennedy et al. IMMUNOLOGICAL REVIEWS
- Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma
- (2008) John A. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More